8 Results for "

HPK1-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "HPK1-IN-2" in MCE Product Catalog:

Cat. No.: HY-132150A
CAS No.: 2375595-72-3
Purity:  98.69%
Target:  

MAP4K FLT3 Src

Research Areas:  

Cancer

HPK1-IN-2 dihydrochloride is an orally active HPK1 inhibitor (IC50 < 0.05 µM) with antitumor activity. HPK1-IN-2 dihydrochloride inhibits the activity of Lck (IC50 < 0.05 µM) and Flt3 (IC50 < 0.05 µM) kinases .
loading...
    loading...
Cat. No.: HY-132150C
Target:  

MAP4K FLT3 Src

Research Areas:  

Cancer

HPK1-IN-2 TFA is an orally active HPK1 inhibitor (IC50 < 0.05 µM) with antitumor activity. HPK1-IN-2 TFA inhibits the activity of Lck (IC50 <0.05 µM) and Flt3 (IC50 < 0.05 µM) kinases .
loading...
    loading...
Cat. No.: HY-W761300
CAS No.: 2446913-96-6
Target:  

Ligands for E3 Ligase

Research Areas:  

Others

1-(4-Pip-Ph)-DHP-dione is an E3 ligase ligand. 1-(4-Pip-Ph)-DHP-dione can be used for synthesis of PROTAC HPK1 Degrader-2 (HY-162544) .
loading...
    loading...
Cat. No.: HY-168283
Research Areas:  

Cancer

HPK1 ligand 2 is a PROTAC target protein ligand (Ligand for Target Protein for PROTAC). HPK1 ligand 2 can be used for synthesis DD205-291 (HY-168282) .
loading...
    loading...
Cat. No.: HY-162544
CAS No.: 2893885-31-7
Target:  

PROTACs MAP4K

Research Areas:  

Cancer

PROTAC HPK1 Degrader-2 (compound 3) is a PROTAC degrader of HPK1, with the DC50 of 23 nM in human PBMC. PROTAC HPK1 Degrader-2 plays an important role in cancer research .
loading...
    loading...
Cat. No.: HY-162546
Research Areas:  

Cancer

3-hydroxypropanoic acid-pip-hydroquinone-dihydrouracil is a conjugate of E3 ligase ligand and linker that serve as a key intermediate for the synthesis of complete PROTAC HPK1 Degrader-2 (HY-162544) .
loading...
    loading...
Cat. No.: HY-162545
CAS No.: 2893885-42-0
Research Areas:  

Cancer

HPK1-IN-47 is a HPK1 ligand. HPK1-IN-47 can be used for synthesis of PROTACs, such as PROTAC HPK1 Degrader-2 (HY-162544). HPK1-IN-47 can be used for research of HPK1-mediated diseases including cancer .
loading...
    loading...
Cat. No.: HY-159905
CAS No.: 3048537-48-7
Target:  

MAP4K

Research Areas:  

Inflammation/Immunology

HPK1-IN-54 is a potent HPK1 (Hematopoietic Progenitor Kinase 1) inhibitor that enhances T cell activation and proliferation by inhibiting HPK1 activity, thereby exhibiting antitumor effects. Its IC50 value against HPK1 is 2.67 nM, with excellent selectivity over the MAP4K family (>100-fold) and other selected kinases (>300-fold). HPK1-IN-54 displayed moderate in vivo clearance and reasonable oral exposure in mice and rats. Additionally, HPK1-IN-54 demonstrated strong antitumor efficacy in a CT26 murine colon cancer model and synergistic effects when combined with anti-PD-1 (HY-P9902A). HPK1-IN-54 shows promise for research in the field of immunotherapy .
loading...
    loading...